Dow Down 0.17% Nasdaq Down 0.28%

Supernus Pharmaceuticals, Inc. (SUPN)

-NasdaqGM
8.69 Down 0.15(1.70%) Sep 30, 4:00PM EDT
|After Hours : 8.69 Up 0.00 (0.05%) Sep 30, 4:39PM EDT
Prev Close:8.84
Open:8.85
Bid:N/A
Ask:8.78 x 2500
1y Target Est:12.08
Beta:1.54
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:8.62 - 8.85
52wk Range:5.84 - 11.47
Volume:548,326
Avg Vol (3m):438,691
Market Cap:372.98M
P/E (ttm):N/A
EPS (ttm):-1.59
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SUPN

Comparison

Symbol% ChgMkt Cap
SUPNDown 1.70%372.98M
JNJUp 0.05%300.61B

Key Statistics

Forward P/E (1 yr):27.16
P/S (ttm):7.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.10
Quarterly EPS Est (Sep-14) :0.36
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback